Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that patients with Spondylarthropathies in
remission under antiTNF therapy, can maintain the remission with a maintenance dose inferior
to the currently recommended dose schedule.